News

Pharmacology and Clinical Efficacy of Erdosteine in Chronic Obstructive Pulmonary Disease Maurizio Moretti Disclosures Expert Rev Resp Med. 2007;1 (3):307-316. 0 ...
Carlos Noujeim; Pierre Bou-Khalil Disclosures Expert Rev Resp Med. 2013;7 (4):429-437.
Mucolytics are a class of drugs used to break up and thin mucus and make it easier to clear from the airways by coughing it up. Mucolytics, such as Mucinex (guaifenesin), are used to treat respiratory ...
Bronchitis is an infection of the tubes that lead to the lungs. It can be acute or chronic. Symptoms include a cough and wheezing. Smoking is a major risk factor. Find out more.
Chronic kidney disease (CKD) affects millions worldwide. It is a long-term condition where the kidneys do not work as well as they are supposed to. Though it is a common condition, many people don ...
Acute bronchitis, the infectious form of which affects most people with the disease, is only very rarely fatal. Chronic bronchitis, however, can slowly destroy lung function and may become life ...
Research from Norway shows longer daily walks could improve chronic lower back pain, with those walking over 100 minutes experiencing lower risk despite intensity.
MPC-inhibitor 0602K shows significant preservation of lean mass & increased muscle function combined with tirzepatide in pre-clinical DIO models0602K shows profound beneficial transformation of ...
In the vagina, chronic yeast infections can happen when there’s an imbalance or variation in vaginal bacteria. These bacteria normally help keep Candida from overgrowing.
Chronic obstructive pulmonary disease, or COPD, describes an ongoing group of lung conditions that includes chronic bronchitis and emphysema. It is the result of damaged lung tissue, which leads ...
Chronic bronchitis was assessed retrospectively from the patients' records by means of the clinical definition proposed by a Ciba symposium 17 — namely, productive cough, occurring on most days ...
GRAND RAPIDS, Mich., June 20, 2025 /PRNewswire/ -- Cirius Therapeutics, Inc., a developer of innovative therapies for patients suffering from diseases caused by insulin resistance, including ...